Scarnose International Ltd
Incorporated in 2011, Scarnose International
Ltd is in the business of Animal Food Products.[1]
- Market Cap ₹ 11.9 Cr.
- Current Price ₹ 37.7
- High / Low ₹ 89.9 / 35.9
- Stock P/E 1,188
- Book Value ₹ 30.9
- Dividend Yield 0.00 %
- ROCE 0.10 %
- ROE 0.10 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -20.9% over past five years.
- Company has a low return on equity of 0.72% over last 3 years.
- Company has high debtors of 347 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Textiles Textiles & Apparels Other Textile Products
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.00 | 12.05 | 32.55 | 95.65 | 41.07 | 13.86 | 12.06 | 10.08 | |
| 0.01 | 0.00 | 12.01 | 32.26 | 95.36 | 41.13 | 14.12 | 11.97 | 10.13 | |
| Operating Profit | 0.00 | 0.00 | 0.04 | 0.29 | 0.29 | -0.06 | -0.26 | 0.09 | -0.05 |
| OPM % | 0.00% | 0.33% | 0.89% | 0.30% | -0.15% | -1.88% | 0.75% | -0.50% | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.28 | 0.17 | 0.28 | 0.17 | 0.07 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.02 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.00 | 0.00 | 0.04 | 0.30 | 0.45 | 0.06 | 0.01 | 0.25 | 0.01 |
| Tax % | 25.00% | 26.67% | 24.44% | 16.67% | 100.00% | 24.00% | 0.00% | ||
| 0.00 | 0.00 | 0.03 | 0.23 | 0.33 | 0.04 | 0.01 | 0.19 | 0.01 | |
| EPS in Rs | 0.00 | 0.00 | 30.00 | 5.48 | 1.69 | 0.13 | 0.03 | 0.60 | 0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -21% |
| 3 Years: | -37% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -47% |
| 3 Years: | -37% |
| TTM: | -95% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -21% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 0.42 | 1.95 | 3.15 | 3.15 | 3.15 | 3.15 |
| Reserves | 0.00 | 0.00 | 0.03 | 1.49 | 1.44 | 6.88 | 6.40 | 6.57 | 6.58 |
| 0.00 | 0.00 | 0.00 | 0.01 | 2.89 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 12.01 | 2.66 | 6.14 | 5.08 | 0.04 | 0.21 | 0.05 | |
| Total Liabilities | 0.01 | 0.01 | 12.05 | 4.58 | 12.42 | 15.11 | 9.59 | 9.93 | 9.78 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | 0.06 | 0.05 | 0.04 | 0.03 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.11 | 0.11 | 0.06 | 0.06 |
| 0.01 | 0.01 | 12.05 | 4.58 | 11.57 | 14.94 | 9.43 | 9.83 | 9.69 | |
| Total Assets | 0.01 | 0.01 | 12.05 | 4.58 | 12.42 | 15.11 | 9.59 | 9.93 | 9.78 |
Cash Flows
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 0.00 | -0.01 | -0.77 | 0.49 | -5.44 | -0.59 | 0.33 | -1.93 | ||
| 0.00 | 0.00 | -0.57 | -1.75 | -0.79 | 0.29 | -0.46 | 1.98 | ||
| 0.00 | 0.00 | 1.65 | 1.06 | 6.57 | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow | 0.00 | -0.01 | 0.31 | -0.20 | 0.34 | -0.31 | -0.13 | 0.05 | |
| Free Cash Flow | 0.00 | -0.01 | -0.77 | -0.27 | -4.81 | -0.59 | 0.33 | -1.93 | |
| CFO/OP | 0% | -238% | 203% | 9,067% | 223% | 467% | 3,860% |
Ratios
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 365.00 | 41.27 | 36.98 | 92.52 | 141.42 | 1.21 | 347.26 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Days Payable | 21.91 | ||||||||
| Cash Conversion Cycle | 0.00 | 365.00 | 41.27 | 15.86 | 92.52 | 141.42 | 1.21 | 347.26 | |
| Working Capital Days | 0.00 | 1.21 | 13.68 | 7.86 | 66.12 | 204.62 | 230.62 | 346.17 | |
| ROCE % | 0.00% | 160.00% | 30.61% | 13.41% | 1.10% | 0.10% | 2.59% | 0.10% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Number of permanent employees count |
|
||
| Animal Food Supplements revenue share % of total revenue |
|||
| Organic Fertilizers revenue share % of total revenue |
|||
Extracted by Screener AI
Documents
Announcements
- Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- 15Th Annual General Meeting ('AGM') Of The Company To Be Held On Wednesday, 16Th September, 2026 At 4:00 P.M. Through Video Conferencing ('VC') / Other Audio Video Means ('OAVM').
- Reg. 34 (1) Annual Report.
-
Considered And Recommended The Material Related Party Transactions
- Board approved AGM notice; 15th AGM on 16 September 2026 and recommended three related-party transactions.
Business Overview:[1]
SIL specializes in the manufacturing, trading, warehousing, clearing and forwarding, purchasing and selling, marketing, and brand establishment of a wide range of products. These include active pharmaceutical ingredients
(APIs), oncology drugs, antibiotics, vaccines, pharmaceutical formulations, personal hygiene products, fertilizers, and agricultural chemicals, catering to human, animal, and agricultural
needs.